{
    "2021-08-08": [
        [
            {
                "time": "",
                "original_text": "【开源零售|周视角】伊美尔拟赴港IPO，医美机构资本化持续推进",
                "features": {
                    "keywords": [
                        "伊美尔",
                        "赴港IPO",
                        "医美机构",
                        "资本化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医美行业周报：梳理瘦身减重药物 期待利拉鲁肽国内进展",
                "features": {
                    "keywords": [
                        "医美行业",
                        "瘦身减重药物",
                        "利拉鲁肽",
                        "国内进展"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}